The adoption of cell therapy and regenerative medicine require the development of robust, scalable manufacturing tools and workflows to generate sufficient high-quality cells for infusion into patients. GE Healthcare Life Sciences’ Xuri Cell Expansion System W25 is suitable for manufacturing cellular immunotherapies in a clinical setting. The functionally closed, automated system is equipped with dedicated software applications to make it suitable for a regulated manufacturing environment and has been validated for T-cell growth. GE Healthcare
Print this page
Related